Dihexa Dosing & Reconstitution Guide
Dosing Protocol
Route: Oral (sublingual/capsule) or Intranasal Frequency: Once daily Dose Range: Oral: 0.5–2 mg/day; Intranasal: 0.5–1.5 mg/day Timing: Morning or early afternoon; avoid evening (may disrupt sleep)
Storage
Lyophilized: −20 °C (−4 °F) Reconstituted: 2–8 °C (35.6–46.4 °F) Shelf Life: 28 days
Safety & Contraindications
Safety: No human safety data exists whatsoever Short-duration animal studies report no apparent toxicity at research dosages Potent HGF/c-Met activation raises theoretical oncological concerns (c-Met pathway involved in tumor progression)
Contraindications: No established contraindications due to complete absence of human data; Theoretical: active cancer (HGF/c-Met pathway is involved in tumor progression and metastasis); Pregnancy and breastfeeding (no safety data)